Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.
Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, Novak J, Zak P, Szotkowski T, Koristek Z, Krekeler C, Unglaub JM, Sauer T, Ruhnke L, Kraus S, Schaffrath J, Müller LP, Kaes S, Niemann D, Fransecky L, Hess PP, Crysandt M, Jost E, Millo J, Gaertner J, Repp R, Jentzsch M, Hoppe L, Klein S, Modemann F, Michalowski N, Fischbach K, Blau W, Ruhs M, Ritter M, Lohmeyer J, Steffen B, Hauser S, Kaufmann M, Krause SW, Knabe R, Spiekermann K, Serve H, Platzbecker U, Baldus CD, Müller-Tidow C, Lenz G, Reinhardt HC, Mayer J, Bornhäuser M, Röllig C, Schliemann C, Hanoun M. Ronnacker J, et al. Among authors: modemann f. Leukemia. 2025 Sep;39(9):2174-2180. doi: 10.1038/s41375-025-02700-9. Epub 2025 Jul 21. Leukemia. 2025. PMID: 40691504 Free PMC article.
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemia.
Klingler F, Forstreuter A, Stegat L, Kämereit S, Ullrich F, Udonta F, Krebs C, Wichmann D, Bokemeyer C, Goekbuget N, Fiedler W, Modemann F. Klingler F, et al. Among authors: modemann f. Haematologica. 2025 Jul 1;110(7):1660-1664. doi: 10.3324/haematol.2024.286972. Epub 2025 Mar 13. Haematologica. 2025. PMID: 40079089 Free PMC article. No abstract available.
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
Knabe R, Muller P, Schliemann C, Hanoun M, Unglaub JM, Weinbergerová B, Mayer J, Krekeler C, Krause SW, Kaufmann M, Kraus S, Steffen B, Modemann F, Subklewe M, Bücklein V, Kunz WG, Rudelius M, von Bergwelt-Baildon M, Gutmair K, Hoster E, Herold T, Röllig C, Spiekermann K. Knabe R, et al. Among authors: modemann f. Blood Adv. 2025 Jul 8;9(13):3336-3339. doi: 10.1182/bloodadvances.2024014570. Blood Adv. 2025. PMID: 39993233 Free PMC article. No abstract available.
A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents.
Shahswar R, Gabdoulline R, Krueger K, Wichmann M, Götze KS, Braitsch K, Meggendorfer M, Schmalbrock L, Bullinger L, Modemann F, Fiedler W, Krauter J, Kaun S, Rotermund S, Voß A, Behrens YL, Bergmann AK, Koller E, Beutel G, Thol F, Heidel F, Heuser M. Shahswar R, et al. Among authors: modemann f. Leukemia. 2025 Mar;39(3):614-622. doi: 10.1038/s41375-024-02501-6. Epub 2025 Jan 8. Leukemia. 2025. PMID: 39779979 Free PMC article.
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures.
Schoof M, Godbole S, Albert TK, Dottermusch M, Walter C, Ballast A, Qin N, Olivera MB, Göbel C, Neyazi S, Holdhof D, Kresbach C, Peter LS, Epplen GD, Thaden V, Spohn M, Blattner-Johnson M, Modemann F, Mynarek M, Rutkowski S, Sill M, Varghese J, Afflerbach AK, Eckhardt A, Münter D, Verma A, Struve N, Jones DTW, Remke M, Neumann JE, Kerl K, Schüller U. Schoof M, et al. Among authors: modemann f. Nat Commun. 2023 Nov 24;14(1):7717. doi: 10.1038/s41467-023-43564-w. Nat Commun. 2023. PMID: 38001143 Free PMC article.
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia.
Gottschlich A, Thomas M, Grünmeier R, Lesch S, Rohrbacher L, Igl V, Briukhovetska D, Benmebarek MR, Vick B, Dede S, Müller K, Xu T, Dhoqina D, Märkl F, Robinson S, Sendelhofert A, Schulz H, Umut Ö, Kavaka V, Tsiverioti CA, Carlini E, Nandi S, Strzalkowski T, Lorenzini T, Stock S, Müller PJ, Dörr J, Seifert M, Cadilha BL, Brabenec R, Röder N, Rataj F, Nüesch M, Modemann F, Wellbrock J, Fiedler W, Kellner C, Beltrán E, Herold T, Paquet D, Jeremias I, von Baumgarten L, Endres S, Subklewe M, Marr C, Kobold S. Gottschlich A, et al. Among authors: modemann f. Nat Biotechnol. 2023 Nov;41(11):1618-1632. doi: 10.1038/s41587-023-01684-0. Epub 2023 Mar 13. Nat Biotechnol. 2023. PMID: 36914885 Free PMC article.
25 results